title: Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS.
authors.affiliation: Department of Laboratory Medicine, Uji-Tokushukai Medical Center, Uji, Japan.
authors.forename: Shinsaku
authors.initials: S
authors.lastname: Imashuku
mesh_terms: D002986:Clinical Trials as Topic; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008137:Longitudinal Studies; D019636:Neurodegenerative Diseases / Q000209:etiology* / Q000628:therapy
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors